In the hours after Turing Pharmaceuticals CEO Martin Shkreli became America's Public Enemy No. 1, the leaders of the country's powerful drug industry trade group got together to determine whether they should weigh in and, if so, what they should say.
In its more than 55 years in existence, the Pharmaceutical Research and Manufacturers of America (PhRMA) has been known to circle the wagons and protect its own when there is controversy. With the tens of millions it spends on lobbying a year, the organization is credited with being able to sway sen...
Also read: AT&T Chief Hits Foes of Time Warner Deal